Soleno Therapeutics Ownership | Who Owns Soleno Therapeutics?
Soleno Therapeutics Ownership Summary
Soleno Therapeutics is owned by 29.59% institutional investors, 2.10% insiders, and 68.31% retail investors. Fmr is the largest institutional shareholder, holding 15.85% of SLNO shares. Vanguard Health Care Inv is the top mutual fund, with 3.83% of its assets in Soleno Therapeutics shares.
SLNO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Soleno Therapeutics | 29.59% | 2.10% | 68.31% |
| Sector | Healthcare Stocks | 232.64% | 10.66% | -143.30% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 8.00M | 15.85% | $540.78M |
| Janus henderson group | 5.19M | 12.39% | $233.13M |
| Price t rowe associates inc /md/ | 3.90M | 7.73% | $263.84M |
| Blackrock funding, inc. /de | 3.87M | 7.26% | $179.26M |
| Vanguard group | 3.06M | 5.74% | $141.69M |
| Blackrock | 1.86M | 5.15% | $76.03M |
| Avoro capital advisors | 2.58M | 5.11% | $174.26M |
| Wellington management group llp | 2.31M | 4.58% | $156.30M |
| Vivo capital | 2.28M | 4.51% | $154.01M |
| State street | 2.17M | 4.30% | $146.90M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ally bridge group (ny) | 302.48K | 12.45% | $20.45M |
| Vivo capital | 2.28M | 12.39% | $154.01M |
| Artia global partners lp | 672.18K | 7.19% | $45.44M |
| Tri locum partners lp | 450.58K | 7.00% | $30.46M |
| Great point partners | 225.00K | 6.27% | $15.21M |
| Catalio capital management, lp | 418.25K | 5.23% | $28.27M |
| Commodore capital lp | 1.35M | 4.46% | $91.26M |
| Ghost tree capital | 300.00K | 3.83% | $12.24M |
| Diadema partners lp | 177.33K | 3.07% | $11.99M |
| Braidwell lp | 1.28M | 2.57% | $86.66M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 8.00M | 0.03% | 4.66M |
| Wellington management group llp | 2.31M | 0.03% | 1.69M |
| Blackrock | 1.86M | 0.00% | 1.54M |
| Braidwell lp | 1.28M | 2.57% | 1.28M |
| Janus henderson group | 5.19M | 0.12% | 1.11M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 1.40M | 0.15% | -2.17M |
| Vivo capital | 2.28M | 12.39% | -1.68M |
| Vestal point capital, lp | - | - | -1.06M |
| Point72 asset management | - | - | -916.00K |
| Westfield capital management co lp | - | - | -899.16K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Braidwell lp | 1.28M | 2.57% | 1.28M | $86.66M |
| Hood river capital management | 613.39K | 0.49% | 613.39K | $41.47M |
| Logos global management lp | 350.00K | 1.84% | 350.00K | $15.73M |
| Kingdon capital management | 301.00K | 2.53% | 301.00K | $20.35M |
| Abrdn | 287.46K | 0.02% | 287.46K | $13.31M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Tortoise investment management | -2.00 |
| Stephens consulting | -3.00 |
| Cornerstone planning group | -4.00 |
| Harbour investments | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 119 | -57.65% | 15,780,535 | -75.81% | 29 | 0.18% | 75 | -56.90% | 29 | -49.12% |
| Sep 30, 2025 | 103 | -60.08% | 13,634,031 | -75.97% | 27 | 0.21% | 72 | -55.28% | 21 | -60.38% |
| Jun 30, 2025 | 257 | 1.58% | 56,707,474 | 5.32% | 112 | 0.83% | 162 | 14.89% | 51 | -10.53% |
| Mar 31, 2025 | 260 | 35.42% | 54,569,843 | 6.92% | 118 | 0.80% | 145 | 12.40% | 59 | 110.71% |
| Dec 31, 2024 | 49 | -68.59% | 6,917,396 | -85.32% | 16 | 0.13% | 35 | -66.02% | 6 | -75.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 1.98M | 3.83% | 718.19K |
| Vanguard Total Stock Mkt Idx Inv | 1.64M | 3.17% | 3.77K |
| State Street® SPDR® S&P® Biotech ETF | 1.60M | 3.10% | 8.82K |
| T. Rowe Price US All-Cap Opp Eq Comp | 1.32M | 2.56% | -132.50K |
| iShares Russell 2000 ETF | 1.14M | 2.20% | 1.14M |
| Strategic Advisers Fidelity US TtlStk | 1.08M | 2.08% | 26.10K |
| Polar Capital Biotech S Inc | 1.07M | 2.08% | - |
| Fidelity Advisor Growth Opps M | 1.04M | 2.02% | - |
| Vanguard US Total Market Shares ETF | 913.59K | 1.99% | - |
| Janus Henderson Global Life Sciences | 1.00M | 1.94% | -13.36K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 27, 2026 | Manning Meredith | Chief Commercial Officer | Sell | $146.10K |
| Mar 27, 2026 | Manning Meredith | Chief Commercial Officer | Sell | $65.18K |
| Mar 27, 2026 | Manning Meredith | Chief Commercial Officer | Sell | $17.70K |
| Mar 27, 2026 | Huang Michael F. | Sr. VP of Clinical Development | Sell | $127.84K |
| Mar 27, 2026 | Huang Michael F. | Sr. VP of Clinical Development | Sell | $57.05K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 83 |
SLNO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools